probucol has been researched along with Cerebral Arterial Diseases in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Cerebral Arterial Diseases: Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Probucol has a potent antioxidative effect, inhibits the oxidation of LDL, and reduces xanthomas." | 2.82 | Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease. ( Arai, H; Bujo, H; Fukushima, M; Kagimura, T; Kita, T; Masuda, D; Matsuzaki, M; Matsuzawa, Y; Ohama, T; Saito, Y; Yamashita, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, S | 1 |
| Masuda, D | 1 |
| Ohama, T | 1 |
| Arai, H | 1 |
| Bujo, H | 1 |
| Kagimura, T | 1 |
| Kita, T | 1 |
| Matsuzaki, M | 1 |
| Saito, Y | 1 |
| Fukushima, M | 1 |
| Matsuzawa, Y | 1 |
1 trial available for probucol and Cerebral Arterial Diseases
| Article | Year |
|---|---|
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cerebral Arterial | 2016 |